Top of this page
Skip navigation, go straight to the content
Categories
UCB Stories
-
Using our innovative antibody know-how to enhance the power of nature
Posted by 13-Sep-2021
-
Our R&D Response to COVID-19: A Patients’ First Approach
Posted by 10-Sep-2021
-
The pursuit of continuous innovation
Posted by 08-Sep-2021
-
UCB’s Braine site: Biopharma’s best-kept secret
Posted by 02-Sep-2021
-
With more than 90 years of innovation behind us, we are looking to the future
Posted by 07-Jul-2021
-
UCB is proud to partner on a new EU Research Project – ‘HIPPOCRATES’ – to improve diagnostic and therapeutic options for patients living with Psoriatic Arthritis
Posted by 05-Jul-2021
-
How AI is accelerating the development of new treatments for specific patient populations
Posted by 28-Jun-2021
-
Clinical Trial Day: Honoring our Clinical Researchers
Posted by 20-May-2021
-
Hackathon Brings Together Diverse Talents for Digital Innovation
Posted by 19-Mar-2021
-
Delivering Patient Value Faster Than Ever
Posted by 04-Mar-2021
Tag cloud
- R&D
- COVID-19
- AAV
- Handl Therapeutics
- Innovation
- AI
- clinical studies
- partnership
- UCB
- research
- antibodies
- innovation
- PD
- Partnerships
- immunology
- UK
- Research
- IMI
- collaboration
- epilepsy
- Partnership
- clinical trials
- osteoporosis
- partnerships
- Neurology
- Parkinson's disease
- transparency
- lupus
- SLE
- Roch Doliveux